2C-T-4

2C-T-4 (also known as 2,5-dimethoxy-4-isopropylthiophenethylamine) is a psychedelic drug and phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin and described in his book PiHKAL (Phenethylamines I Have Known And Loved).

History

2C-T-4 was first synthesized and tested for psychoactivity by Alexander Shulgin in 1986. Shulgin's findings were later published in his book PiHKAL. The substance is part of the 2C family, a group of phenethylamines whose chemical structure includes two carbon atoms between the amine group and the benzene ring.

Chemistry

2C-T-4 is a phenethylamine with a chemical formula of C13H21NO2S. It is structurally similar to other drugs of the 2C family, which are characterized by the presence of two carbon atoms between the amine group and the benzene ring. The 'T' in 2C-T-4 stands for 'thio', which refers to the sulfur atom in the molecule, and the '4' indicates the position of the isopropyl group on the benzene ring.

Pharmacology

Like other 2C drugs, 2C-T-4 is believed to act as a 5-HT2A receptor agonist. However, the exact mechanism of action is not fully understood. The drug's effects are thought to be due to its activity at the 5-HT2A receptor, which is involved in the regulation of mood, anxiety, and perception.

Effects

The effects of 2C-T-4 are similar to those of other psychedelic drugs. Users may experience visual hallucinations, altered perception of time, enhanced introspection, and changes in thought processing. The duration of effects can vary, but typically lasts between 4 and 8 hours.

Legal Status

The legal status of 2C-T-4 varies by country. In the United States, it is classified as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess without a license.

See Also

• 2C-T-2
• 2C-T-7
• 2C-B
• Psychedelic drug
• Phenethylamine

2C-T-4 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski